Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(5.84%),Robert Atchinson(5.84%), etc.
Heron Therapeutics | 8-K: Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
Heron Therapeutics | 10-Q: Q3 2024 Earnings Report
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Heron Therapeutics | 8-K: Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
Heron Therapeutics | 10-Q: Q2 2024 Earnings Report
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
No Data
No Data